SFS
ANIX icon

Strategic Financial Services’s Anixa Biosciences ANIX Stock Holding History

Strategic Financial Services’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,250
Closed -$83K – 121
2019
Q4 		$83K Buy
+25,250
New +$92.6K 0.01% 133

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Strategic Financial Services's ANIX Position: Q1 2020 in Review

Strategic Financial Services sold out of Anixa Biosciences (ANIX) in Q1 2020, closing a stake of 25,250 shares — an estimated $83K sold.

Strategic Financial Services first reported a position in ANIX in Q4 2019 and held it in 1 quarter. The position peaked at $83K in Q4 2019. 17 funds tracked by Wall St. Rank hold ANIX as of Q1 2020.

  • Strategic Financial Services reported no remaining Anixa Biosciences position as of Q1 2020 after selling out during the quarter.
  • Strategic Financial Services sold 25,250 Anixa Biosciences shares in Q1 2020, an estimated $83K.
  • Strategic Financial Services first reported a position in Anixa Biosciences in Q4 2019 and held it in 1 quarter.
  • Strategic Financial Services's Anixa Biosciences position peaked at $83K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2020.

Based on Strategic Financial Services's 13F filing for Q1 2020, filed 8 May 2020.